Rep. Rick Larsen discloses trade(s) in ABT, APH, MCK, SPGI
Rick Larsen (WA02) disclosed 4 transactions, traded Jul 8: 2 purchases and 2 sales.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| Jul 8 | ABT | Abbott Laboratories | Sell | $1,001 - $15,000 | Self |
| Jul 8 | APH | Part of advisor-driven quarterly rebalancing Amphenol Corporation | Buy | $1,001 - $15,000 | Self |
| Jul 8 | MCK | Part of advisor-driven quarterly rebalancing McKesson Corporation | Buy | $1,001 - $15,000 | Self |
| Jul 8 | SPGI | Part of advisor-driven quarterly rebalancing S&P Global Inc. | Sell | $1,001 - $15,000 | Self |
ORIGINAL FILING ↗ALL FILINGS BY RICK LARSEN →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
A U.S. House member has filed financial disclosures showing transactions in four large-cap stocks spanning healthcare, industrial components, pharmaceuticals distribution, and financial services. Congressional stock trading disclosures are public record and tracked by markets observers for potential conflicts of interest or signals of legislative intent, though individual trades by members do not typically move markets on their own.
Sources (1)
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- Hon. Rick LarsenSep 29, 2026View the original filing at the House Clerk ↗
How This Could Play Out
First assessed Sep 29
Resolved
UNLIKELYA formal investigation or enforcement action finding no violation would likely have minimal direct market impact on the four stocks, as the disclosure itself already satisfies transparency requirements and routine rebalancing typically carries no systemic implications.
Status quo
LIKELYThese trades remain routine congressional disclosures with no follow-up scrutiny or media amplification, leaving the four stocks unaffected by any legislative or reputational pressure tied to the transaction.
Worsens
POSSIBLEIf media or watchdog groups flag the timing or pattern of these trades as suspicious relative to committee work or legislative activity, heightened scrutiny could create temporary reputational headwinds for the affected stocks or broader pressure on congressional trading norms, though the magnitude would depend on the severity of alleged impropriety.
More on Congressional Stock Trading
- Rep. Julie Johnson discloses trade(s) in WBDNov 10
- Rep. Gilbert Cisneros discloses trade(s) in ARE, LNT, APP, ARGX, BNSNov 10
- Rep. Charles J. "Chuck" Fleischmann files a Periodic Transaction ReportNov 10
- Rep. Thomas Suozzi files a Periodic Transaction ReportNov 9
- Rep. David Kustoff discloses trade(s) in WBDNov 9
- Rep. Nancy Pelosi discloses trade(s) in WBDNov 6
Get the market digest by email
One email each morning: yesterday's key story and what it means for markets. Free.